Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shyam Ganti MD, MBBS"'
Autor:
James Crosby DO, Tosha Erzuah MD, Mahvish Haider DO, Forrest Smith DO, Shyam Ganti MD, MBBS, Gregory Monohan MD, Raymond Elsouiedi MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 10 (2022)
Secondary malignancies including leukemia are an increasing concern in patients with prior primary malignancies treated with alkylating agents or topoisomerase II inhibitors. These can also be referred to as therapy-related leukemia. Therapy-related
Externí odkaz:
https://doaj.org/article/7e8fa5014ae044c886c1ede17453b1a9
Autor:
Crosby James DO, Karim Amidou Abdul MD, Barisere Bodo MD, Abdelmohaymin Abdalla MBBS, Ana C. Zamora MD, James Abraham MD, Subramanya Shyam Ganti MD, MBBS
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 11 (2023)
With the previous worldwide initial coronavirus disease 2019 (COVID-19) pandemic, a notable rise in spontaneous pneumomediastinum with/without pneumothorax (SPP) has been noted. Most cases were initially reported as complications secondary to barotra
Externí odkaz:
https://doaj.org/article/2fd9f94d10874ae08c269cd4918fa21f
Autor:
James Crosby DO, Sarah Semon MD, Subramanya Shyam Ganti MD, MBBS, Enid Klauber-Choephel MD, James Abraham MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 10 (2022)
The Delta variant of COVID-19 has been associated with severe disease causing a surge in the second half of 2021. Atypical pathogens can be present in those in particular with severe ARDS and can contribute to excess morbidity and mortality. We must
Externí odkaz:
https://doaj.org/article/bc90b3cd7dc044d8be5279a2a6e824f2
Autor:
James Crosby DO, Huzefa Bhopalwala MD, Amrin Kharawala MD, Nakeya Dewaswala MD, Subramanya Shyam Ganti MD, MBBS, Adnan Bhopalwala MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 9 (2021)
Dofetilide, a class III antiarrhythmic, is widely used in the treatment of cardiac arrhythmias. Antiarrhythmic drugs can have a long duration of action that prolongs the QT interval. This causes bradycardia that predisposes to R-on-T phenomenon subse
Externí odkaz:
https://doaj.org/article/3643bf9358114d8e90d31280a44dd036